| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 6 | |
| #2 | Australia | 4 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | China | 2 | |
| #5 | WIPO (World Intellectual Property Organization) | 2 | |
| #6 | Canada | 1 | |
| #7 | India | 1 | |
| #8 | New Zealand | 1 | |
| #9 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Metselaar Josbert Maarten | 21 |
| #2 | Czarny Bertrand Marcel Stanislas | 5 |
| #3 | Wong Chee Wai | 5 |
| #4 | Wong Tina Tzee Ling | 4 |
| #5 | Storm Gerrit | 4 |
| #6 | Schiffelers Raymond Michel | 2 |
| #7 | Molema Grietje | 2 |
| #8 | Wauben Marca Henriette Michael | 1 |
| #9 | Wauben Marca Henriette M | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CN109906075A | Liposome corticosteroid for the locally injecting in inflammation lesion or region | |
| CA2854430A1 | Liposomal corticosteroids for treatment of inflammatory disorders in humans | |
| US2009226509A1 | Composition for treatment of inflammatory disorders |